Analysts rate Heartbeam Inc. (BEAT:NSD) with a Buy rating and a $12 target

STA Research
by: STA Research
Beat stock forecast

Based on the Heartbeam stock forecast from 1 analyst, the average analyst BEAT stock price target is $12.00 over the next 12 months. Heartbeam Inc’s average analyst rating is Buy. Stock Target Advisor’s own stock analysis of BEAT stock forecast is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, BEAT stock price was USD 2.32BEAT stock price has changed by +1.04% over the past week, +0.77% over the past month and +0.00% over the last year.

 

About Heartbeam Inc. (BEAT:NSD):

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

 

 

Most Recent Analyst Ratings for Beat’s stock:

 

 

What we like:

Underpriced compared to book value:

BEAT stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior capital utilization:

Heartbeam management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

 

What we don’t like:

Low market capitalization:

BEAT stock is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns:

Heartbeam is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns, the returns are unpredictable. Proceed with caution.

High volatility:

The total returns for Heartbeam are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings:

BEAT stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow:

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow:

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth:

BEAT stock has shown below median earnings growth in the previous 5 years compared to its sector.

 

 

Disclaimer

Stock Target Advisor is not a broker/dealer, investment advisor, or platform for making stock buying or selling decisions. Our goal is to democratize and simplify financial information through automated analysis, aggregation of stock information, and education to help investors with their research. No content on our site, blogs or newsletters constitutes – or should be understood as constituting – a recommendation to enter into any securities transactions or to engage in any of the investment strategies presented in our site content. We also cannot guarantee the accuracy of any information presented on our site and in our analysis.

Leave a Reply

Your email address will not be published.